Senegal Health & Pharma: Senegal became the first African country to locally manufacture a generic sickle cell treatment, DREPAF (hydroxyurea-based), produced by Teranga Pharma with Drep.Afrique, with marketing authorisation in April 2025 and distribution starting in early 2026—aimed at improving access and lowering costs across six target African markets. Senegal Public Finance: Moody’s further downgraded Senegal’s sovereign credit rating from Caa1 to Caa2, citing higher default risk tied to persistent liquidity pressures, refinancing challenges, and reliance on more expensive regional markets. Energy & Power (Regional, with Senegal assets): Abu Dhabi’s ePointZero (2PointZero Group) agreed to buy a 90% stake in Azura Power, which operates in Nigeria, Senegal and Mozambique (including Senegal’s Tobene plant), as Africa’s electricity demand is expected to nearly double by 2040. Water & Agriculture (Senegal): President El Ghazouani inspected a water supply project for 165 villages using water from the Senegal River, also including irrigation for 3,500 hectares to boost agricultural capacity. ECOWAS Tourism: ECOWAS adopted a framework to strengthen and accredit regional tourism business associations across West Africa, pushing for better governance and credibility. Trade & Food Industry (Regional): India’s BIRC 2026 is drawing 3,317 buyers from 138 countries, including Senegal, signaling potential new food trade routes for rice exporters.